In neuroblastoma, ALK mutations are mostly activating missense single nucleotide variants (SNV) leading to increased kinase activity by disrupting the auto-inhibited conformation of the kinase [5, 6], thereby promoting tumor growth, proliferation, and migration [7]. This evidence concerns the gene ALK and neoplasm.